Tandem Diabetes Care (Nasdaq:TNDM) today announced study findings highlighting the benefits of its automated insulin delivery ...

Dexcom (Nasdaq:DXCM) today filed an SEC form to announce that Chair and CEO Kevin Sayer is taking a temporary medical leave ...

Medtronic (NYSE:MDT) today shared real-world evidence highlighting improvements with its MiniMed 780G automated insulin ...

Modular Medical (Nasdaq:MODD) announced that it received Institutional Review Board (IRB) approval to study its ...

Insulet (Nasdaq:PODD) announced today that it appointed Flavia Pease to succeed Ana Maria Chadwick as EVP and CFO.

Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery.

The FDA identified a recall of smartphone apps for Dexcom (Nasdaq:DXCM) continuous glucose monitors as the most serious type.

BD (NYSE:BDX) announced that it expanded its Class I voluntary recall for its Alaris Pump Module model 8100 infusion system.

Insulet (Nasdaq:PODD) has its eyes on future expansion in new geographies, according to some of its leading executives.

Teleflex (NYSE: TFX) announced today that it enrolled the first patient in its DUBSTENT DIABETES drug-eluting device trial.

Elutia announced today that it agreed to sell its bioenvelope technologies to Boston Scientific for $88 million.

Dexcom (Nasdaq:DXCM) filed with the state of California to confirm plans to lay off more than 300 employees in San Diego.